Z
Zura Bio Limited (ZURA)
NCM – Real vaqt narxi. Valyuta: USD
4.75
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.75
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Zura Bio Limited, klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda autoimmün va yallig'lanish kasalliklari uchun dori vositalarini ishlab chiqadi. Kompaniya Tibulizumabni ishlab chiqmoqda, bu IgG4 yagona zanjirli o'zgaruvchan fragmentli bispesifik antitelodir, u bitta terapevtik molekulada IL-17A va BAFFni bog'lash va zararsizlantirish uchun ishlab chiqilgan bo'lib, u 2-bosqich klinik sinovlari rivojlanishida. U, shuningdek, Torudokimab (ZB-880) ni ishlab chiqmoqda, bu interleykin-33 ga yo'naltirilgan to'liq inson IgG4 monoklonal antitelosi bo'lib, u 1-bosqich klinik tadqiqotlarini yakunlagan; va Crebankitug (ZB-168), interleykin-7 retseptorining alfa qismiga yo'naltirilgan to'liq inson IgG1 monoklonal antitelosi bo'lib, u 1-bosqich klinik tadqiqotlarini yakunlagan. Zura Bio Limited 2022 yilda tashkil etilgan va Henderson, Nevada shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Kiran Nistala MBBS, Ph.D. | Chief Medical Officer & Head of Development |
| Dr. Sandeep C. Kulkarni M.D. | Co-Founder, CEO & Director |
| Dr. Someit Sidhu M.D. | Co-Founder & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | zura-20260507.htm |
| 2026-04-30 | DEF 14A | tm261622-1_def14a.htm |
| 2026-04-23 | 8-K | tm2612540d1_8k.htm |
| 2026-03-19 | 8-K | tm269296d1_8k.htm |
| 2026-03-19 | 10-K | zura-20251231x10k.htm |
| 2026-03-10 | 8-K | tm268344d1_8k.htm |
| 2026-03-05 | 8-K | tm268054d1_8k.htm |
| 2026-02-26 | 8-K/A | tm267392d1_8ka.htm |
| 2026-02-26 | 8-K | tm267297d1_8k.htm |
| 2026-02-23 | 8-K | tm267035d1_8k.htm |